English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

acetylsalicylic acid/hemorrhage

The link is saved to the clipboard
Page 1 from 59 results

IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19

Only registered users can translate articles
Log In/Sign up
Between 30 and 50% of patients who contract COVID 19 will be asymptomatic or oligosymptomatic. This fact will not give rise to the consult, and will directly affect a notorious sub-registration of the cases. The second, even more disturbing, premise is that these patients are as contagious as the

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

Only registered users can translate articles
Log In/Sign up

Omega 3 and Ischemic Stroke; Fish Oil as an Option

Only registered users can translate articles
Log In/Sign up
Introduction and Background According to the Center of Disease Control and Prevention, stroke is the 5th leading cause of mortality in the US, and a leading cause of significant long-term disability where almost 50% of stroke survivors, age 65 and above, suffer from disabling decrease in mobility.

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

Only registered users can translate articles
Log In/Sign up
It is a investigator-initiated, compassionate use, prospective, phase 2b, non randomized, open-label, proof of concept study in which the investigators will evaluate the effects of compassionate-use treatment with IV tirofiban, associated with acetylsalicylic acid PO, clopidogrel PO and fondaparinux

PercutaNEOus Coronary Intervention folloWed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial

Only registered users can translate articles
Log In/Sign up
Based on current scientific evidence, acute coronary syndrome (ACS) subjects should be treated with dual antiplatelet therapy (DAPT), which consists of the association of acetylsalicylic acid (ASA) with an oral antagonist of platelet P2Y12 receptor. Clinical trials have shown that DAPT reduces

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Only registered users can translate articles
Log In/Sign up
EXISTING KNOWLEDGE AND MAIN ASSUMPTIONS OF THE PROJECT. Atherosclerosis is the most common cause of peripheral artery disease (PAD). The first symptom of PAD is intermittent claudication (IC), which is characterized by the occurrence of pain, cramps, numbness, and discomfort in the lower limb

Study to Learn More About the Effectiveness and Safety of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Patients Suffering From a Condition That Affects the Blood Vessels Supplying the Heart (CAD) and/or a Condition That Affects the Blood Vessel of the Lower Limbs (PAD).

Only registered users can translate articles
Log In/Sign up

Inflammatory Markers in Hysterectomies

Only registered users can translate articles
Log In/Sign up

Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation

Only registered users can translate articles
Log In/Sign up
Rationale: Thromboembolic- and bleeding events can occur after TAVI and can have great consequences. There is currently no evidence-based guideline on prevention of thromboembolic events after TAVI and the current standard of care with DAPT 3-6 months is based on expert opinion. Recently multislice

Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis

Only registered users can translate articles
Log In/Sign up
Research question To study whether dietary supplementation with L. reuteri ATCC PTA 4659 (Lr4659) is safe and can reduce the relapse rate and have a positive effect in patients with ulcerative colitis (UC). Lr4659 is a naturally occurring strain of human origin. It is a typical member of the L.

Vascular Healing After Implantation of FANTOM Bioresorbable Scaffold in STEMI: A FANTOM STEMI Study

Only registered users can translate articles
Log In/Sign up
The aim of the study is to evaluate the acute safety and feasibility of implantation of the sirolimus-eluting bioresorbable Fantom scaffold BVS in the setting of ST segment elevation myocardial infarction (STEMI), as well as the mid and long-term clinical efficacy and healing pattern of the device,

Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA

Only registered users can translate articles
Log In/Sign up
INTRODUCTION Post-implantation syndrome is the clinical and biochemical expression of an inflammatory response following endovascular repair of an aortic aneurysm.1 PIS is mainly a clinical condition associated with the implantation of an endograft and is diagnosed by the presence of fever

Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction

Only registered users can translate articles
Log In/Sign up
Randomization to study drugs shall be performed using an online database system for data collection; the assigned arm and the randomisation code will be generated after entering basic patient data based on a predefined randomization scheme. Concomitant therapy. Acetylsalicylic acid - 500 mg i.v.

Haemostasis Management of Abdominal Aortic Procedures

Only registered users can translate articles
Log In/Sign up
Despite the fact that interventional therapy of vascular lesions (endovascular and hybrid procedures) is becoming more and more common, angioplasties involving major vessels have to be still managed as surgical procedures associated with extreme high demand for transfusion, this applies especially

GLOBAL LEADERS Adjudication Sub-Study

Only registered users can translate articles
Log In/Sign up
The GLOBAL LEADERS trial was designed to determine the benefits and risks of an antithrombotic regimen using ticagrelor 90 mg BID combined with low-dose (75 mg OD) acetylsalicylic acid (ASA) for one month followed by ticagrelor 90 mg BID alone for 23 months, compared to conventional dual
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge